Kineta Garners $942,000 New Financing Round

  • Feed Type
  • Date
    1/9/2010
  • Company Name
    Kineta
  • Mailing Address
    307 Westlake Ave North Seattle, WA 98109
  • Company Description
    Kineta Inc. was formed in December 2007 by a group of scientists who are globally recognized for several breakthrough discoveries about the human immune system and the body’s reaction to the Hepatitis C virus. Through Kineta, our pioneering team is dedicated to further study of innate immunity with an aggressive strategy to develop early stage programs for powerful new antiviral and immune modulating drugs. We believe our unique approach will yield a new class of drugs to respond to diseases caused by viruses such as, Influenza, Hepatitis C and West Nile virus: diseases that afflict millions of people. This novel field of research is also applicable to dozens of autoimmune diseases. We believe in our science and our ability to improve lives around the world.
  • Website
    http://www.kinetabio.com
  • Transaction Type
    Debt, Venture Equity
  • Transaction Amount
    $942,000
  • Transaction Round
    Undisclosed
  • Proceeds Purposes
    Proceeds purposes were not disclosed.
  • M&A Terms
  • Venture Investor
    Undisclosed

By posting a comment, you agree to our terms and conditions.